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Abstract
Lues maligna is a rare presentation of an infection with Treponema pallidum. Here we report three lues maligna infections
with severe dermatological manifestations in a single HIV-1 infected individual. Despite the start of highly active anti-
retroviral therapy and a substantial increase in CD4 cell count after the first episode, he developed consecutive episodes.
We assume a specific immunological predisposition to react to T. pallidum in this patient.
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Introduction
Syphilis infections are frequent among HIV-infected
individuals, especially men who have sex with men;
however, it seldom presents with lues maligna. This
clinical entity represents a rare dermatologic manifest-
ation of secondary syphilis and is also known as
‘ulcero-nodular syphilis’ or ‘malignant syphilis’.1,2
Reinfection is a possibility,8 however this has not
been described in HIV infection. Here we describe an
HIV-infected individual who developed malignant
syphilis with three consecutive infections.
Case report
A bisexual man in his 40 s presented to our infectious
diseases outpatient department for skin lesions three
times (in 2010, 2012 and 2014). He had been diagnosed
with HIV infection in 2003. With each episode, the
patient suffered from non-specific symptoms such as
headache, malaise and subfebrile temperatures.
Striking was a disseminated exanthema presenting
with ulcerating nodules (Figure 1(a)) for months. The
patient’s skin in 2010 (Figure 1(b)) showed multiple
disseminated polymorphic lesions all over the body
without itchiness. In 2012, the skin lesions were not
as many as two years before but the rate of ulceration
increased. In 2014 (Figure 1(c)), the skin manifestations
were even less but got bigger and more ulcerated. The
serological tests proved active syphilis in every case.
Treponema pallidum particle agglutination assays
(TPPA) for syphilis were positive (2010: 320,000,
2012: 1.28 million, 2014: 320,000) and rapid plasma
reagin (RPR) titre increased (2010: 1:128, 2012: 1:32
and 2014: 1:256). Lumbar puncture was performed
and neurosyphilis was excluded. The patient reported
promiscuous unprotected sexual contacts in the past.
Each time he was treated with ceftriaxone 2 g intra-
venously once daily for three weeks due to the extensive
dermatologic manifestation. To prevent a Jarisch–
Herxheimer reaction we added oral prednisolone
1mg/kg body weight only for the first day of treatment.
The non-specific flu-like symptoms disappeared quickly
within days. All skin lesions healed, partly with scars
within three weeks (Figure 1(d)). RPR titres slowly
decreased (to 1:4 after the first episode and to 1:16
after the second episode. The patient did not return
to our outpatient department after the treatment of
the third episode).
He started highly active antiretroviral therapy
(HAART) consisting of raltegravir 400mg bid,
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darunavir 800mg qd, ritonavir 100mg qd and tenofovir
245mg qd with the first episode in 2010. His CD4 cell
count increased from 360 ml1 (22%) to 506 ml1 (44%)
and his viral load ranged between <50 and 200 copies/
ml while on HAART. Written informed consent was
obtained regarding the publishing of clinical data and
images.
Discussion
Lues maligna is predominantly found in immunodefi-
cient patients such as patients with HIV or AIDS1–6 but
also occurs in immunocompetent individuals.7 The
classic lesion of lues maligna is an oval, papulopustular
skin lesion with well-demarcated borders sometimes
covered with a lamellar crust (Figure 1(a)), but
myriad clinical presentations of this disease also exist.
Differential diagnosis includes vasculitis, lymphoma,
leishmaniasis, pyoderma gangrenosum and varicella
zoster infections among others.2 Although the clinical
manifestations of lues maligna are complicated and
severe, the response to antibiotic treatment (benzathine
penicillin or ceftriaxone) is excellent.4
Interestingly, the patient presented here developed
the course of malignant syphilis three times despite
the start of HAART after the first episode. As he
received adequate antibiotic treatment with ceftriaxone,
we assume reinfection for the two following episodes.
To our knowledge, this is the second case reported after
the first case report in 1978.8 An immunocompromised
state, a certain virulent bacterial strain or a unique
characteristic of the immune response is discussed as
reasons for malignant syphilis.7,8 In our patient, the
CD4 count improved after HAART start and he had
three independent infections which render a virulent
strain three times in a row unlikely. Therefore, our
hypothesis is that the patient’s immune system is pre-
disposed for developing this kind of reaction to
Treponema pallidum.
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